Evaluation of HCPTd1, d14-double passaged intervening chemotherapy protocol for hepatocellular carcinoma

Table 1 Tumor-emboli volume after treatment

	Tumor volume Cases	CR	PR	NC	PD Cases	Dis	Red	Un-ch	Prog	Portal vein emboli
Test	116	6	66	43	1	69	8	53	6	2
Control I	124	1	39	76	8	72	1	9	38	24
Control II	86	1	47	36	2	51	2	16	21	12

CR: complete response; PR: partial response; NC: no change; Dis: disappear; Red: reduction; PD: progressive disease; Un-ch: unchanged; Prog: progression.

Table 2 Hepatic cancerous marker alterations before and after treatment

	Hepatic cancerous marker
	AFP				GGT-II
	P	N	D	I	P	N	D	I
Test	62	16	44	2	94	29	60	5
Control I	65	1	33	31	74	6	22	46
Control II	52	5	30	17	82	8	49	25

P: positive; N: negative; D: decrease; I: increase.